PLA2G7 c.1166T>C ;(p.L389S)

Variant ID: 6-46672913-A-G

NM_005084.3(PLA2G7):c.1166T>C;(p.L389S)

This variant was identified in 6 publications

View GRCh38 version.




Publications:


Lipoprotein-associated phospholipase A2: The story continues.

Medicinal Research Reviews
Huang, Fubao F; Wang, Kai K; Shen, Jianhua J
Publication Date: 2020-01

Variant appearance in text: PLA2G7: Leu389Ser; rs34159425
PubMed Link: 31140638
Variant Present in the following documents:
  • Main text
  • MED-40-79.pdf
View BVdb publication page



Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.

Cell Reports
Cheng, Hui H; Yang, Xinping X; Si, Han H; Saleh, Anthony D AD; Xiao, Wenming W; Coupar, Jamie J; Gollin, Susanne M SM; Ferris, Robert L RL; Issaeva, Natalia N; Yarbrough, Wendell G WG; Prince, Mark E ME; Carey, Thomas E TE; Van Waes, Carter C; Chen, Zhong Z
Publication Date: 2018-10-30

Variant appearance in text: PLA2G7: L389S; rs34159425
PubMed Link: 30380422
Variant Present in the following documents:
  • NIHMS1511993-supplement-6.xlsx, sheet 1
View BVdb publication page



Lipoprotein-associated phospholipase A2 and risk of incident peripheral arterial disease: Findings from The Atherosclerosis Risk in Communities study (ARIC).

Atherosclerosis
Garg, Parveen K PK; Norby, Faye L FL; Polfus, Linda M LM; Boerwinkle, Eric E; Gibbs, Richard A RA; Grove, Megan L ML; Folsom, Aaron R AR; Garimella, Pranav S PS; Matsushita, Kunihiro K; Hoogeveen, Ron C RC; Ballantyne, Christie M CM
Publication Date: 2018-01

Variant appearance in text: rs34159425
PubMed Link: 29169030
Variant Present in the following documents:
  • Main text
View BVdb publication page



Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib.

Plos One
Yeo, Astrid A; Li, Li L; Warren, Liling L; Aponte, Jennifer J; Fraser, Dana D; King, Karen K; Johansson, Kelley K; Barnes, Allison A; MacPhee, Colin C; Davies, Richard R; Chissoe, Stephanie S; Tarka, Elizabeth E; O'Donoghue, Michelle L ML; White, Harvey D HD; Wallentin, Lars L; Waterworth, Dawn D
Publication Date: 2017

Variant appearance in text: PLA2G7: L389S; rs34159425
PubMed Link: 28753643
Variant Present in the following documents:
  • Main text
  • pone.0182115.pdf
  • pone.0182115.s014.xlsx, sheet 1
View BVdb publication page



Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene.

Pharmaceuticals (Basel, Switzerland)
Stafforini, Diana M DM
Publication Date: 2009-11-20

Variant appearance in text: PLA2G7: L389S
PubMed Link: 27713227
Variant Present in the following documents:
  • pharmaceuticals-02-00094.pdf
View BVdb publication page



Coronary heart disease and genetic variants with low phospholipase A2 activity.

The New England Journal Of Medicine
Polfus, Linda M LM; Gibbs, Richard A RA; Boerwinkle, Eric E
Publication Date: 2015-01-15

Variant appearance in text: PLA2G7: L389S; rs34159425
PubMed Link: 25587968
Variant Present in the following documents:
  • Main text
View BVdb publication page